aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
5.71
-0.28 (-4.67%)
At close: Jul 21, 2025, 4:00 PM
5.76
+0.05 (0.85%)
After-hours: Jul 21, 2025, 7:59 PM EDT

aTyr Pharma Stock Forecast

Stock Price Forecast

The 6 analysts that cover aTyr Pharma stock have a consensus rating of "Strong Buy" and an average price target of $20.2, which forecasts a 253.77% increase in the stock price over the next year. The lowest target is $9 and the highest is $35.

Price Target: $20.2 (+253.77%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$9.00$20.2$16$35
Change+57.62%+253.77%+180.21%+512.96%
* Price targets were last updated on Jun 20, 2025.

Analyst Ratings

The average analyst rating for aTyr Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy222222
Buy444444
Hold000000
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Maintains
$17$25
BuyMaintains$17$25+337.83%Jun 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong BuyReiterates$35+512.96%Jun 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong BuyReiterates$35+512.96%May 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong BuyReiterates$35+512.96%Mar 14, 2025
Leerink Partners
Leerink Partners
Buy
Initiates
$16
BuyInitiates$16+180.21%Feb 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.53M
from 235.00K
Increased by 551.06%
Revenue Next Year
30.21M
from 1.53M
Increased by 1,874.58%
EPS This Year
-0.68
from -0.86
EPS Next Year
-0.71
from -0.68
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
10.46M-10.39M353.00K235.00K1.53M30.21M163.94M
Revenue Growth
2,377.49%---96.60%-33.43%551.06%1,874.58%442.65%
EPS
-1.77-1.77-1.60-0.94-0.86-0.68-0.710.25
EPS Growth
--------
Forward PE
-------22.65
No. Analysts
-----121210
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High12.6M123.9M328.7M
Avg1.5M30.2M163.9M
Lown/an/a45.4M

Revenue Growth

Revenue Growth20252026202720282029
High
5,261.7%
7,998.0%
987.8%
Avg
551.1%
1,874.6%
442.7%
Low--
50.2%

EPS Forecast

EPS20252026202720282029
High-0.58-0.431.04
Avg-0.68-0.710.25
Low-0.77-1.26-0.31

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.